• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Phathom









































































First wave start date is Nov. 6th. Second wave Dec 11th. 322 total reps in the U.S. I'm interviewing for the 2nd wave start date, had a recruiter phone screen, then a virtual with hiring manager, in-person with hiring manager, and today virtual with a regional peer before a final next week. I've been impressed through the whole process.